DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 215 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $158 | -63.2% | 12,720 | -58.6% | 0.00% | -75.0% |
Q4 2023 | $429 | -61.4% | 30,693 | -59.2% | 0.00% | -69.2% |
Q3 2023 | $1,112 | +56.6% | 75,308 | +4.0% | 0.01% | +62.5% |
Q1 2023 | $710 | -99.7% | 72,403 | +203.9% | 0.01% | +166.7% |
Q3 2022 | $249,000 | -28.7% | 23,823 | -14.1% | 0.00% | -25.0% |
Q2 2022 | $349,000 | -25.7% | 27,729 | -17.0% | 0.00% | +33.3% |
Q4 2021 | $470,000 | -46.3% | 33,402 | -26.8% | 0.00% | -25.0% |
Q3 2021 | $876,000 | +335.8% | 45,625 | +122.8% | 0.00% | +300.0% |
Q1 2021 | $201,000 | +279.2% | 20,481 | +71.7% | 0.00% | – |
Q4 2020 | $53,000 | -91.5% | 11,930 | -91.7% | 0.00% | -100.0% |
Q3 2020 | $623,000 | +938.3% | 144,300 | +753.5% | 0.00% | +300.0% |
Q1 2020 | $60,000 | -56.5% | 16,907 | +87.1% | 0.00% | 0.0% |
Q2 2018 | $138,000 | +21.1% | 9,036 | +57.8% | 0.00% | 0.0% |
Q1 2018 | $114,000 | -29.2% | 5,726 | -33.5% | 0.00% | -50.0% |
Q4 2017 | $161,000 | -43.9% | 8,617 | -35.4% | 0.00% | -33.3% |
Q3 2017 | $287,000 | +129.6% | 13,334 | +12.0% | 0.00% | +200.0% |
Q3 2016 | $125,000 | +21.4% | 11,904 | +182.4% | 0.00% | 0.0% |
Q3 2015 | $103,000 | -29.9% | 4,215 | -35.6% | 0.00% | 0.0% |
Q1 2015 | $147,000 | – | 6,540 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |